Our data demonstrate that SAHA-mediated elevation of IL-35 plays a role in this amelioration which was ascertained by treating Ebi3−/− and the corresponding wild-type with SAHA and by comparing colitis manifestation in both strains. The gene discussed is EBI3; the disease is colitis.